Author
Listed:
- Joshua A. Hill
(University of Washington
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center
Clinical Research Division, Fred Hutchinson Cancer Center)
- Yeon Joo Lee
(Infectious Diseases Service, Department of Medicine, Memorial Sloan Kettering Cancer Center
Weill Cornell Medical College)
- Lisa K. Vande Vusse
(University of Washington)
- Hu Xie
(Clinical Research Division, Fred Hutchinson Cancer Center)
- E. Lisa Chung
(Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center)
- Alpana Waghmare
(Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center
Seattle Children’s Hospital)
- Guang-Shing Cheng
(University of Washington
Clinical Research Division, Fred Hutchinson Cancer Center)
- Haiying Zhu
(University of Washington)
- Meei-Li Huang
(University of Washington)
- Geoffrey R. Hill
(Clinical Research Division, Fred Hutchinson Cancer Center
Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center)
- Keith R. Jerome
(Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center
University of Washington)
- Wendy M. Leisenring
(Clinical Research Division, Fred Hutchinson Cancer Center)
- Danielle M. Zerr
(Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center
Seattle Children’s Hospital)
- Sina A. Gharib
(University of Washington)
- Sanjeet Dadwal
(City of Hope National Medical Center)
- Michael Boeckh
(University of Washington
Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center
Clinical Research Division, Fred Hutchinson Cancer Center)
Abstract
Limited understanding of the immunopathogenesis of human herpesvirus 6B (HHV-6B) has prevented its acceptance as a pulmonary pathogen after hematopoietic cell transplant (HCT). In this prospective multicenter study of patients undergoing bronchoalveolar lavage (BAL) for pneumonia after allogeneic HCT, we test blood and BAL fluid (BALF) for HHV-6B DNA and mRNA transcripts associated with lytic infection and perform RNA-seq on paired blood. Among 116 participants, HHV-6B DNA is detected in 37% of BALs, 49% of which also have HHV-6B mRNA detection. We establish HHV-6B DNA viral load thresholds in BALF that are highly predictive of HHV-6B mRNA detection and associated with increased risk for overall mortality and death from respiratory failure. Participants with HHV-6B DNA in BALF exhibit distinct host gene expression signatures, notable for enriched interferon signaling pathways in participants clinically diagnosed with idiopathic pneumonia. These data implicate HHV-6B as a pulmonary pathogen after allogeneic HCT.
Suggested Citation
Joshua A. Hill & Yeon Joo Lee & Lisa K. Vande Vusse & Hu Xie & E. Lisa Chung & Alpana Waghmare & Guang-Shing Cheng & Haiying Zhu & Meei-Li Huang & Geoffrey R. Hill & Keith R. Jerome & Wendy M. Leisenr, 2024.
"HHV-6B detection and host gene expression implicate HHV-6B as pulmonary pathogen after hematopoietic cell transplant,"
Nature Communications, Nature, vol. 15(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-44828-9
DOI: 10.1038/s41467-024-44828-9
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:15:y:2024:i:1:d:10.1038_s41467-024-44828-9. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.